Clinical trial

Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

NCT02736474

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE4

Study timeline

Study start (actual)2016-05-01Date precision: month

Registry last updated2021-10-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obeseunresolved

Cigarette-smokingunresolved

Schizophreniaunresolved

Interventions

NaltrexoneDRUG · verified · RxNorm: naltrexone

Placebo NaltrexoneDRUG

BupropionDRUG · verified · RxNorm: bupropion

Placebo BupropionDRUG

Sponsors & collaborators

Shanghai Mental Health Centerlead sponsor

University of Massachusetts, Worcestercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02736474 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.